Shares of Hindustan Unilever were trading lower in Wednesday's session. The stock price was Rs 2,518.10, a decline of 0.35% on the NSE as of 10:20 am, compared to the previous day's close. As of today's session, 199,973 shares have been traded.
On July 10, 2025, Hindustan Unilever Ltd announced the cessation of Mr. Rohit Jawa as MD & CEO of the Company effective close of business hours on 31st July 2025.
Hindustan Unilever Financials
Here is a summary of Hindustan Unilever's key financial data.
Consolidated Quarterly Results
The following table presents the consolidated quarterly results for Hindustan Unilever:
Heading
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
Rs 15,210.00 Crore
Rs 15,707.00 Crore
Rs 15,926.00 Crore
Rs 15,818.00 Crore
Rs 15,670.00 Crore
Net Profit
Rs 2,561.00 Crore
Rs 2,614.00 Crore
Rs 2,601.00 Crore
Rs 2,988.00 Crore
Rs 2,476.00 Crore
EPS
10.89
11.11
11.03
12.70
10.48
The revenue for the quarter ending March 2025 was Rs 15,670.00 Crore, slightly lower than the Rs 15,818.00 Crore in December 2024. The net profit for the same period was Rs 2,476.00 Crore, also lower than the Rs 2,988.00 Crore in the previous quarter.
Consolidated Yearly Results
The following table presents the consolidated yearly results for Hindustan Unilever:
Heading
2021
2022
2023
2024
2025
Revenue
Rs 47,028.00 Crore
Rs 52,446.00 Crore
Rs 60,580.00 Crore
Rs 61,896.00 Crore
Rs 63,121.00 Crore
Net Profit
Rs 8,000.00 Crore
Rs 8,887.00 Crore
Rs 10,145.00 Crore
Rs 10,286.00 Crore
Rs 10,679.00 Crore
EPS
34.03
37.79
43.07
43.74
45.32
BVPS
202.95
208.88
214.99
217.95
210.22
ROE
16.77
18.09
20.11
20.06
21.55
Debt to Equity
0.00
0.00
0.00
0.00
0.00
The revenue for the year ending March 2025 was Rs 63,121.00 Crore, an increase compared to Rs 61,896.00 Crore in March 2024. The net profit for the same period was Rs 10,679.00 Crore, up from Rs 10,286.00 Crore in the previous year.
Consolidated Yearly - Income Statement
The following table presents the consolidated yearly Income Statement:
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Sales
63,121
61,896
60,580
52,446
47,028
Other Income
1,017
811
512
258
410
Total Income
64,138
62,707
61,092
52,704
47,438
Total Expenditure
49,320
48,443
47,632
40,724
36,715
EBIT
14,818
14,264
13,460
11,980
10,723
Interest
395
334
114
106
117
Tax
3,744
3,644
3,201
2,987
2,606
Net Profit
10,679
10,286
10,145
8,887
8,000
The total sales for the year ending March 2025 increased to 63,121 compared to 61,896 in March 2024. The net profit also increased from 10,286 in March 2024 to 10,679 in March 2025.
Consolidated Quarterly - Income Statement
The following table presents the consolidated quarterly Income Statement:
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Sales
15,670
15,818
15,926
15,707
15,210
Other Income
309
232
219
257
231
Total Income
15,979
16,050
16,145
15,964
15,441
Total Expenditure
12,536
11,957
12,487
12,340
11,917
EBIT
3,443
4,093
3,658
3,624
3,524
Interest
80
112
110
93
105
Tax
887
993
947
917
858
Net Profit
2,476
2,988
2,601
2,614
2,561
The total sales for the quarter ending March 2025 stood at 15,670 compared to 15,818 in December 2024. The net profit stood at 2,476 in March 2025 compared to 2,988 in December 2024.
Consolidated Yearly - Cash Flow
The following table presents the consolidated yearly cash flow data:
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Operating Activities
11,886
15,469
9,991
9,048
9,163
Investing Activities
6,473
-5,324
-1,494
-1,728
-1,528
Financing Activities
-13,101
-10,034
-8,953
-8,015
-9,309
Others
0
0
10
0
0
Net Cash Flow
5,258
111
-446
-695
-1,674
Net cash flow increased from 111 in March 2024 to 5,258 in March 2025. Cash flow from operating activities stood at 11,886 in March 2025 compared to 15,469 in March 2024.
Consolidated - Balance Sheet
The following table presents the consolidated balance sheet data:
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Share Capital
235
235
235
235
235
Reserves & Surplus
49,167
50,983
50,069
48,826
47,439
Current Liabilities
16,537
12,876
12,028
11,280
11,103
Other Liabilities
13,941
14,405
10,755
10,176
9,980
Total Liabilities
79,880
78,499
73,087
70,517
68,757
Fixed Assets
37,878
37,303
36,344
35,389
34,791
Current Assets
22,051
21,324
16,998
15,522
14,217
Other Assets
19,951
19,872
19,745
19,606
19,749
Total Assets
79,880
78,499
73,087
70,517
68,757
Contingent Liabilities
3,447
3,314
3,574
3,230
2,985
Total assets increased from 78,499 in March 2024 to 79,880 in March 2025. Total liabilities also increased from 78,499 to 79,880 for the same period.
Consolidated - Ratios
Key financial ratios for Hindustan Unilever:
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Basic EPS (Rs.)
34.03
37.79
43.07
43.74
45.32
Diluted Eps (Rs.)
34.03
37.79
43.07
43.74
45.32
Book Value [Excl. Reval Reserve]/Share (Rs.)
202.95
208.88
214.99
217.95
210.22
Dividend/Share (Rs.)
31.00
34.00
39.00
42.00
53.00
Face Value
1
1
1
1
1
Gross Profit Margin (%)
25.59
25.00
24.20
25.00
25.13
Operating Margin (%)
23.30
22.92
22.32
23.03
22.99
Net Profit Margin (%)
17.00
16.95
16.74
16.61
16.91
Return on Networth / Equity (%)
16.77
18.09
20.11
20.06
21.55
ROCE (%)
19.01
20.29
22.14
21.72
22.91
Return On Assets (%)
11.62
12.59
13.84
13.09
13.33
Current Ratio (X)
1.28
1.38
1.41
1.66
1.33
Quick Ratio (X)
0.96
1.01
1.06
1.34
1.07
Debt to Equity (x)
0.00
0.00
0.00
0.00
0.00
Interest Coverage Ratios (X)
93.69
123.73
128.61
46.33
40.17
Asset Turnover Ratio (%)
68.39
0.74
0.83
0.82
0.80
Inventory Turnover Ratio (X)
13.14
4.25
4.73
4.66
4.61
3 Yr CAGR Sales (%)
15.02
15.51
23.40
14.72
9.71
3 Yr CAGR Net Profit (%)
23.74
21.10
22.47
13.39
9.62
P/E (x)
71.45
54.21
59.45
51.77
49.84
P/B (x)
11.98
9.81
11.95
10.41
10.75
EV/EBITDA (x)
47.09
36.42
40.72
33.97
33.00
P/S (x)
12.15
9.18
9.93
8.61
8.41
The dividend per share increased from Rs 42.00 in March 2024 to Rs 53.00 in March 2025. The P/E ratio decreased from 51.77 to 49.84 during the same period.
Shares of Hindustan Unilever were trading at Rs 2,518.10, a decline of 0.35% on the NSE as of 10:20 am.
